SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-136918
Filing Date
2004-08-10
Accepted
2004-08-10 16:58:32
Documents
6
Period of Report
2004-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 474667
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9990
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9999
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 4248
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 4260
6 RISK FACTORS dex991.htm EX-99.1 135954
  Complete submission text file 0001193125-04-136918.txt   641549
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
OSCIENT PHARMACEUTICALS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-10824 | Film No.: 04964991
SIC: 2835 In Vitro & In Vivo Diagnostic Substances